South Korea vs South Sudan: Prevalence rate of hypertension in men aged 30-79
South Korea
32
in 2019
South Sudan
32.3
in 2019
South Korea rank
158th
South Sudan rank
155th
Prevalence rate of hypertension in men aged 30-79 over time
- South Korea
- South Sudan
How they compare
South Sudan currently reports 32.3 against 32 in South Korea, a difference of 0.3.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was South Korea ahead.
South Korea ranks 158th and South Sudan ranks 155th of 195 countries.
South Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Korea | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 34.25 | 35.1 | 0.85 | South Sudan |
| 2000s | 32.83 | 36.4 | 3.57 | South Sudan |
| 2010s | 31.99 | 34.35 | 2.36 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, South Korea or South Sudan?
- South Sudan, at 32.3 against 32 in South Korea as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between South Korea and South Sudan?
- 0.3, with South Sudan ahead.
- How many years of comparable data are there for South Korea and South Sudan?
- 30 years are reported by both, from 1990 to 2019.
- How do South Korea and South Sudan rank globally for prevalence rate of hypertension in men aged 30-79?
- South Korea ranks 158th and South Sudan ranks 155th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.